Generative AI in Biology Market Size, Share & Trends The Generative AI in Biology Market is gaining momentum as researchers and biotechnology companies increasingly adopt artificial intelligence to accelerate biological research, drug discovery, and molecular design. Generative AI models can analyze complex biological datasets, predict protein structures, generate novel molecular compounds, and support the development of innovative therapies. Growing investments in biotechnology, precision medicine, computational biology, and life sciences research are driving demand for advanced AI-powered solutions. The market is further supported by advancements in large biological models, protein engineering, genomics, and AI-driven laboratory automation. Pharmaceutical companies and research institutions are leveraging generative AI to improve research efficiency, reduce development timelines, and identify promising drug candidates. North America remains a key market due to its strong biotechnology ecosystem and AI investments, while Asia-Pacific is creating new opportunities through expanding life sciences research and digital innovation. The market is expected to gain traction as generative AI becomes increasingly integrated into biological discovery, therapeutic development, and personalized medicine. FULL REPORT - https://dimensionmarketresearch.com/report/generative-ai-in-biology-market/